瑞丰高材：公司合成生物相关产品业务尚处于起步阶段，短期内不会对公司业绩产生较大影响

Core Viewpoint - The company, Ruifeng High Materials, is focusing on the long-term development of synthetic biological materials, with plans for scaling up production and expanding market reach in the coming years [2]. Group 1: Company Development Plans - Ruifeng High Materials' subsidiary, Ruifeng Bio, is engaged in the development of synthetic biological materials, with established technology in polylactic acid, succinic acid, and dextran [2]. - The company has begun normal sales of dextran, actively exploring markets for its use in animal iron supplements, specifically dextran iron [2]. - By 2026, the company plans to further expand the production capacity of dextran and enhance its sales market [2]. Group 2: Business Strategy - The company aims to strengthen and grow its synthetic biological materials business through self-research and collaboration with established technology results [2]. - The synthetic biological product business is still in its early stages and is not expected to significantly impact the company's performance in the short term [2].